NN Investment Partners Holdings’s Elevance Health ELV Stock Holding History

NN Investment Partners Holdings’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$349M	Buy	711,085 +78,238	+12%	+$35.8M	1.88%	6
2021 Q4	$293M	Buy	632,847 +2,029	+0.3%	+$854K	1.47%	13
2021 Q3	$235M	Sell	630,818 -114,304	-15%	-$43.4M	1.3%	14
2021 Q2	$284M	Sell	745,122 -33,961	-4%	-$13M	1.51%	9
2021 Q1	$280M	Sell	779,083 -43,405	-5%	-$14M	1.65%	9
2020 Q4	$264M	Buy	822,488 +18,647	+2%	+$5.72M	1.6%	10
2020 Q3	$216M	Sell	803,841 -81,618	-9%	-$22M	1.4%	15
2020 Q2	$233M	Buy	885,459 +74,627	+9%	+$19.9M	1.57%	12
2020 Q1	$184M	Buy	810,832 +55,103	+7%	+$15M	1.5%	12
2019 Q4	$228M	Buy	755,729 +28,023	+4%	+$7.71M	1.55%	12
2019 Q3	$175M	Buy	727,706 +204,238	+39%	+$56M	1.37%	13
2019 Q2	$148M	Buy	523,468 +374,746	+252%	+$102M	1.17%	17
2019 Q1	$42.7M	Buy	148,722 +16,407	+12%	+$4.75M	0.33%	72
2018 Q4	$34.7M	Buy	132,315 +19,278	+17%	+$5.3M	0.29%	83
2018 Q3	$31M	Buy	113,037 +9,278	+9%	+$2.41M	0.22%	101
2018 Q2	$24.7M	Sell	103,759 -100,599	-49%	-$23.3M	0.18%	122
2018 Q1	$44.9M	Buy	204,358 +31,277	+18%	+$7.35M	0.32%	82
2017 Q4	$38.9M	Sell	173,081 -26,637	-13%	-$5.67M	0.28%	100
2017 Q3	$37.9M	Buy	199,718 +104,583	+110%	+$19.9M	0.24%	110
2017 Q2	$17.9M	Buy	95,135 +12,742	+15%	+$2.29M	0.17%	140
2017 Q1	$13.6M	Buy	82,393 +29,370	+55%	+$4.67M	0.13%	164
2016 Q4	$7.62M	Sell	53,023 -143,782	-73%	-$19.3M	0.07%	207
2016 Q3	$24.7M	Buy	196,805 +53,119	+37%	+$6.86M	0.23%	112
2016 Q2	$18.9M	Sell	143,686 -8,614	-6%	-$1.18M	0.18%	129
2016 Q1	$21.2M	Buy	+152,300	New	+$20.4M	0.2%	118

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

NN Investment Partners Holdings's ELV Position: Q1 2022 in Review

NN Investment Partners Holdings increased its Elevance Health (ELV) stake by 12% in Q1 2022, buying an estimated $35.8M and bringing the position to 711,085 shares worth $349M. The position accounts for 1.88% of the portfolio, ranked #6.

NN Investment Partners Holdings first reported a position in ELV in Q1 2016 and has held it in 25 quarters since. 1,419 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

NN Investment Partners Holdings held 711,085 shares of Elevance Health worth $349M as of Q1 2022.
NN Investment Partners Holdings bought 78,238 Elevance Health shares in Q1 2022, an estimated $35.8M.
Elevance Health made up 1.88% of NN Investment Partners Holdings's portfolio in Q1 2022, its #6 holding.
NN Investment Partners Holdings first reported a position in Elevance Health in Q1 2016 and has held it in 25 quarters since.
1,419 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.